Showing results (1-10 of 76) with videos related to
Sort By:
Pageof 8
The Journal of Clinical Psychiatry|November 1, 1992
Akathisia, suicidality, and fluoxetineM S Hamilton, L A OplerFrontiers in Bioscience : a Journal and Virtual Library|September 5, 2001
Abnormal phospholipid metabolism in schizophrenia: evidence from epidemiological findings, clinical observations, and preliminary clinical trialsM G Opler, L A OplerPsychiatric Developments|January 1, 1987
The positive-negative dimension in schizophrenia: its validity and significanceS R Kay, L A OplerInternational Journal of Psychiatry in Medicine|January 1, 1985
L-dopa in the treatment of negative schizophrenic symptoms: a single-subject experimental studyS R Kay, L A OplerThe Journal of Clinical Psychiatry|May 1, 1991
The role of pimozide in clinical psychiatry: a reviewL A Opler, S S FeinbergComprehensive Psychiatry|January 1, 1994
Psychopharmacologic treatment of negative schizophrenic symptomsL A Opler, D Albert, P M RamirezJournal of Clinical Psychopharmacology|June 1, 1989
The safety of switching rapidly from tricyclic antidepressants to monoamine oxidase inhibitorsD Kahn, J M Silver, L A OplerThe British Journal of Psychiatry : the Journal of Mental Science|October 1, 1986
Significance of positive and negative syndromes in chronic schizophreniaS R Kay, L A Opler, A FiszbeinSchizophrenia Bulletin|January 1, 1987
The positive and negative syndrome scale (PANSS) for schizophreniaS R Kay, A Fiszbein, L A OplerPsychiatric Developments|January 1, 1987
Attention deficit disorder psychosis as a diagnostic categoryL Bellak, S R Kay, L A OplerPageof 8